NORML

JULY 28, 2021

This updated edition reviews over 450 peer-reviewed studies assessing the safety and efficacy of either whole-plant cannabis or cannabinoids for 23 different patient populations.

Cannabinoids 247

Cannabinoids Safety Patients Cannabis 247

NORML

AUGUST 26, 2019

Virginia has been one of the most reluctant states to consider marijuana law reform, though it recently began allowing some forms of cannabis oil for approved patients. And, 2019’s SB 1557 makes it possible for patients to get as much as 10mg of THC in each dose — the same limit as one serving size for edibles in adult-use states.

Legalization 238

Legalization Marijuana Programs Oil 238

MMJ Recs

MAY 25, 2024

However, not many patients know the reasons behind how medical marijuana interacts with the body, so we prepared this comprehensive guide to use as a starting point for those considering cannabis treatment. ECS modulation also aids in managing symptoms of nausea and vomiting in cancer patients undergoing chemotherapy. What is ECS?

Patients 105

Patients Marijuana Cannabinoids Chronic Pain 105

MMJ Recs

NOVEMBER 20, 2023

Epilepsy Management: CBD, in particular, has emerged as an effective treatment for epilepsy, especially in individuals with rare and severe forms of the condition. These compounds may help reduce symptoms and improve the quality of life for patients. The outcomes of these studies have had a profound impact on patient care.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

Cannabis Law Report

AUGUST 10, 2021

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

United Patients Group

JULY 7, 2023

4) Reduces Seizures in Epilepsy Medical cannabis can be used to manage seizures in people with epilepsy. Epilepsy is a neurological disorder characterized by recurrent seizures. Traditional treatments for epilepsy, such as anti-convulsant medications, are not effective for everyone and can have significant side effects.

Chronic Pain 106

Chronic Pain Sleep Epilepsy Conditions 106

Cannabis Law Report

AUGUST 5, 2019

France is searching for patients to take part in an official medical cannabis trial, but users will not be smoking the drug. The two-year experiment is being overseen by the French Agency for Drug Safety (ANSM), which drew up a 13-name committee to explore the possibilities of reform in one of Europe’s largest markets in December 2018.

Medicine 60

Medicine Patients Digestion Epilepsy 60

Veriheal

NOVEMBER 18, 2022

Texas’ medical cannabis program is in the midst of a massive spike in patient registrations. According to the Texas Department of Public Safety Chief Wayne Muller, the state has averaged a 10% month-over-month increase in medical cannabis patients over the last 18 months. Let us know in the comments!

Edibles 98

Edibles Hemp Epilepsy Programs 98

Cannabis Law Report

JUNE 5, 2021

Forbes report… A young boy and his single mother are in the midst of a 1,000-mile walk across the United Kingdom, a journey they are making to raise awareness and funds to provide medicinal cannabis to chronically ill patients. The walk is also serving as a call to action for the U.K. on Twitter or Facebook.

Access 104

Access Epilepsy Therapy Medicine 104

MMJ Recs

NOVEMBER 6, 2023

As the state’s medical cannabis program continues to evolve, patients are presented with a diverse array of MMJ strains and products to explore. Additionally, we’ll take a look at patient reviews of MMJ strains, offering valuable insights into the experiences of those utilizing medical cannabis in New York.

Strains 105

Strains Chronic Pain Patients Dispensary 105

Peninsula Alternative Health

MAY 15, 2019

Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy.

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

Cannabis Law Report

JULY 26, 2021

SciSparc intends to evaluate the efficacy, safety and tolerability of its Proprietary Cannabinoid-Based Treatment- SCI-110. About half to two-thirds of the cases get much better during adolescence[1]; however, adults will generally be more severe patients[2]. TEL AVIV, Israel , July 26, 2021 /PRNewswire/ — SciSparc Ltd.

Research and Development 105

Research and Development Supply Chain Pharmaceutical Treatment 105

The Cannigma

APRIL 19, 2021

In recent years, lawmakers have eased up on a number of cannabis-derived formulations, and since 2015, people with epilepsy can obtain cannabis oil that contains less than 0.5% THC are legal for use by qualifying medical patients. Patients do not need to register with the state or pay a fee to access the medical cannabis program.

Law 106

Law Epilepsy Conditions Programs 106

Cannabis Law Report

SEPTEMBER 12, 2021

Three years ago, he was instrumental in securing the backing of Parliament and the then Prime Minister Theresa May in making the use of medicinal cannabis legal to treat conditions such as rare forms of epilepsy in children. …/… Speaking afterwards, Sir Mike said: “It is very frustrating.

Epilepsy 96

Epilepsy Medicine Safety Conditions 96

Cannabis Law Report

JULY 30, 2019

EMA’s human medicines committee (CHMP) cleared the cannabidiol oral solution for use with clobazam to treat seizures associated with Lennox-Gastaut syndrome or Dravet syndrome for patients aged two and older. Epidiolex is made up of cannabidiol (CBD), one of the hundreds of molecules found in the marijuana plant and contains less than 0.1

Epilepsy 40

Epilepsy Pharmaceutical Medicine Treatment 40

United Patients Group

AUGUST 28, 2023

In this comprehensive guide, United Patients Group , the leading source for patient information on medical marijuana, will explore the current state of research and knowledge on CBD for pets, touching on the potential benefits, safety considerations, and best practices for incorporating CBD products into a pet’s wellness regimen.

Pets 97

Pets CBD Chronic Pain Digestion 97

MMJ Recs

DECEMBER 28, 2023

However, more research is needed to establish standardized treatment protocols and ensure the long-term safety and efficacy of medical marijuana in managing PTSD. Both THC and CBD play roles in managing these symptoms, with some patients finding relief through the use of specific strains or formulations.

Conditions 98

Conditions Chronic Pain Epilepsy Research and Development 98

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. Systematic review and meta-analysis were performed to examine the efficacy and safety of MCs treatment among children.

Safety 52

Safety Cannabinoids Data Events 52

United Patients Group

MAY 31, 2023

However, determining the right CBD dosage can be tricky, as numerous factors may affect its efficacy and safety. CBD has been researched for its reputed therapeutic effects on various conditions, such as chronic pain, epilepsy, anxiety , and sleep disorders.

CBD 105

CBD Chronic Pain Sleep Conditions 105

Veriheal

MARCH 22, 2022

The restrictive program, if legalized, would allow medical patients with certain severe illnesses to access medical cannabis. . Under the current legislation, House Bill 136 would allow medical cannabis access for patients with cancer , multiple sclerosis , chronic pain , epilepsy , chronic nausea , and post-traumatic stress disorder.

Chronic Pain 90

Chronic Pain Epilepsy Programs Cannabis 90

WeedAdvisor

JULY 11, 2019

CBD proved to be life-changing for epilepsy patients, with some preliminary studies indicating that it could help with several other issues, like inflammation. However, there are many unanswered questions about the science, safety, and quality of products containing CBD.”. WeedAdvisor’s Commitment to Consumer Safety. .

CBD 76

CBD Epilepsy Safety Treatment 76

MMJ Recs

NOVEMBER 17, 2023

This article explores the profound impact of MMJ on Maryland communities, shedding light on the medical marijuana benefits experienced by patients and the positive effects it has had on the state’s communities. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

DECEMBER 3, 2021

An analysis from continuous EEG recordings in 17 patients enrolled in the Phase 2 refractory status epilepticus (RSE) study demonstrated a substantial increase in the alpha/delta ratio immediately after the start of IV ganaxolone in 75% of patients. in patients continuing ganaxolone (n=38) and 33.3%

Epilepsy 40

Epilepsy Pharmaceutical Data Clinical Trials 40

Cannabis Law Report

DECEMBER 11, 2021

The UK’s first and highest-rated medical cannabis clinic, Sapphire Medical Clinics , has today announced that it is reducing the cost of its consultations and appointments for patients enrolled through the Sapphire Access Scheme. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.

Access 52

Access Patients Chronic Pain Treatment 52

MMJ Recs

JANUARY 22, 2020

Being a caregiver to a medical marijuana patient is a big responsibility. How Much Medical Marijuana Should I Give My Patient? Plus, everyone responds just a bit differently to MMJ strengths , which is why it’s essential to start slow with a low dose to see how it impacts the patient and helps to manage their symptoms.

Patients 52

Patients Chronic Pain Conditions Topical 52

Cannabis Law Report

SEPTEMBER 28, 2021

DUBLIN–(BUSINESS WIRE)–The “Epilepsy – Pipeline Insight, 2021” clinical trials has been added to ResearchAndMarkets.com’s offering. This Epilepsy – Pipeline Insight, 2021 provides comprehensive insights about 70+ companies and 70+ pipeline drugs in Epilepsy pipeline landscape.

Epilepsy 40

Epilepsy Clinical Trials Research and Development Pharmaceutical 40

MMJ Recs

DECEMBER 13, 2023

While the state has traditionally held a conservative stance on cannabis, there has been a gradual shift in public opinion and legislative action, paving the way for a more inclusive and patient-centric approach to healthcare. Additionally, patients must have exhausted all other available treatment options without finding relief.

Dispensary 52

Dispensary Patients Marijuana Epilepsy 52

Cannabis Law Report

JUNE 5, 2019

The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. Today (30 May) at 09.30 Sick group 1.

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

The Joint Blog

MARCH 16, 2020

According to a new study published in the journal Phytotherapy Research, the sustained use of marijuana in patients with chronic conditions is associated with quality of life maintenance and a lack of cognitive decline. Around 90% of participants self-medicated with cannabis daily.

Patients 49

Patients Marijuana Epilepsy Treatment 49

MMJ Recs

MARCH 2, 2024

In Ohio, accessing medical marijuana involves more than just obtaining a prescription; it requires navigating a complex landscape of dispensaries, regulations, and patient expectations. This guide aims to demystify the process, offering practical advice and insights to help patients make informed decisions.

Dispensary 52

Dispensary Patients Marijuana Education 52

TheAnswerPage

JULY 17, 2022

In 2017, researchers performed an analysis of observational clinical studies on the treatment of refractory epilepsy with cannabidiol (CBD)-based products. Two thirds of patients reported improvement in the frequency of seizures (399/622, 64%). Are CBD-rich extracts more effective at reducing seizures compared to purified CBD products?

Epilepsy 56

Epilepsy Extraction Treatment CBD 56

Veriheal

APRIL 11, 2022

You don’t take that opium poppy and ask a patient to rub it on their lip for morphine. We know that the plant has powerful potential medical effects, but it clearly needs more refinement, more research and more data,” stated Groff, who envisions a future where patients can easily access ailment-targeted cannabis meds.

Pharmaceutical 106

Pharmaceutical Research and Development DEA Clinical Trials 106

Veriheal

NOVEMBER 10, 2020

The experiment consists of a two-year cycle where up to 3,000 patients will be treated with medical cannabis. The ANSM plans to implement a patient registry which will be updated by doctors and pharmacies after getting consent from patients. About the Experiment. Where Does Cannabis Legality Stand in France?

Chronic Pain 90

Chronic Pain Pharmaceutical Patients Epilepsy 90

Cannabis Law Report

AUGUST 17, 2021

reduction in 28-day seizure frequency relative to baseline in tuberous sclerosis complex (TSC) patients (n=23). reduction was observed in focal seizures (n=19), the most common seizure type in TSC patients. Phase 3 planning for TrustTSC trial ongoing with first patient expected to be enrolled in Q4 2021. RADNOR, Pa.–(BUSINESS

Pharmaceutical 76

Pharmaceutical Clinical Trials Treatment Patients 76

MMJ Recs

OCTOBER 2, 2023

California has been a trailblazer in the realm of medical marijuana, offering patients access to a variety of treatment options. Patients must first schedule an appointment with a licensed medical professional who can evaluate their medical history and condition. In 1996, the state became the first in the U.S.

Dispensary 52

Dispensary Patients Environment Conditions 52

Cannabis Law Report

AUGUST 19, 2019

There have been more than 7,500 approvals for medicinal cannabis in Australia since legalisation in 2016 – so why don’t we know if it is helping patients? Access to medicinal cannabis for patients was legalised in Australia in 2016, allowing doctors to request permission to prescribe from the Australian government.

Medicine 45

Medicine Patients Clinical Trials Access 45

Cannabis Law Report

AUGUST 21, 2019

The watchdog refused to allow its national health service to prescribe medical cannabis for children with severe epilepsy because there is “not enough evidence it works”, a decision which angered campaigners and parents who said their children will suffer as a result. This would answer questions about safety and efficacy, they said.

Clinical Trials 81

Clinical Trials Nerve Pain Medicine Epilepsy 81